Understanding how defensins affect urinary tract infections
Genetic dissection of defensin signaling in urinary tract infections
This study is looking at how certain natural proteins in the body, called defensins, help fight off urinary tract infections (UTIs) caused by specific bacteria, with the hope of finding better treatments for people who struggle with these infections and don’t respond well to antibiotics.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Dallas NIH-funded |
| Lab location | 1 site (Richardson, United States) |
| Project ID | NIH-10936336 on NIH RePORTER |
What this research studies
This research investigates the role of defensins, which are antimicrobial peptides, in urinary tract infections (UTIs) caused by specific bacteria. By using genetically modified mouse models, the study aims to explore how these defensins interact with the urinary system and their impact on both infection resistance and pelvic pain. The goal is to uncover new insights that could lead to more effective treatments for UTIs, especially for patients who do not respond well to current antibiotic therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals, particularly elderly women, who experience recurrent urinary tract infections and have not found relief with standard antibiotic treatments.
Not a fit: Patients with UTIs caused by non-uropathogenic bacteria or those who do not have recurrent infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new immune therapies that significantly improve treatment outcomes for patients suffering from recurrent urinary tract infections.
How similar studies have performed: Previous research has shown promise in understanding the role of antimicrobial peptides in other infections, suggesting that this approach could yield valuable insights, although the specific focus on urinary tract infections is relatively novel.
Where this research is happening
Richardson, United States
- University of Texas Dallas — Richardson, United States (Active)
Researchers
- Principal investigator: Dong, Xintong — University of Texas Dallas
- Study coordinator: Dong, Xintong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.